MD-Bio

MD-Bio is a private Texas-based health diagnostics and medical device company focused on rapid screening and testing products. The company commercializes harm-reduction drug test strips and kits for substances including fentanyl, xylazine, nitazenes, medetomidine, and benzodiazepines, as well as multi-substance and drink-spiking test products. MD-Bio was launched during the COVID-19 pandemic and has also marketed infectious disease testing solutions, including COVID-19 screening products and a research-use-only qPCR monkeypox detection assay. Public materials also describe MD-Bio as a subsidiary brand or company associated with DetectaChem, serving healthcare, public health, first responder, and community harm-reduction markets. Overall, MD-Bio appears to be a commercially active diagnostics manufacturer rather than a therapeutics developer.